These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 122852)

  • 1. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice.
    Batchelor BR; Stern JS; Johnson PR; Mahler RJ
    Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
    Chen NG; Tassava TM; Romsos DR
    J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.
    Cuendet GS; Loten EG; Jeanrenaud B; Renold AE
    J Clin Invest; 1976 Nov; 58(5):1078-88. PubMed ID: 993331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.
    Tassava TM; Okuda T; Romsos DR
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E338-43. PubMed ID: 1550226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice.
    Okuda T; Romsos DR
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity.
    Dubuc PU
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E550-5. PubMed ID: 1415535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin production by pancreatic islets of obese-hyperglycemic mice cultured for one week in different glucose concentrations.
    Andersson A; Asplund K; Larkins R
    Acta Physiol Scand; 1978 Dec; 104(4):377-85. PubMed ID: 364930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
    Mahler RJ
    Acta Diabetol Lat; 1981; 18(1):1-17. PubMed ID: 6452013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice.
    Lenzen S; Klöppel G
    Endocrinology; 1978 Nov; 103(5):1546-55. PubMed ID: 371951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glucose and lipid metabolism in genetically obese mice lacking aP2.
    Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS
    Endocrinology; 2000 Sep; 141(9):3388-96. PubMed ID: 10965911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.
    Le Marchand Y; Loten EG; Assimacopoulos-Jeannet F; Forgue ME; Freychet P; Jeanrenaud B
    Diabetes; 1977 Jun; 26(6):582-90. PubMed ID: 140828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic beta-cells.
    Lundquist I; Alm P; Salehi A; Henningsson R; Grapengiesser E; Hellman B
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1055-63. PubMed ID: 14534076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob).
    Edvell A; Lindström P
    Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.